Unknown OBSERVATIONAL NCT02451046

Usefulness of Alpha-GST in Liver Transplantation (GST-LT)

Predictive Ability of Alpha-GST to Detect Graft Primary Dysfunction After Liver Transplantation

Sponsor: Beaujon Hospital

Conditions Evidence of Liver Transplantation

Updated 7 times since 2017 Last updated: May 20, 2015 Started: Mar 31, 2014 Primary completion: Oct 31, 2015 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Evidence of Liver Transplantation, this trial is ongoing. The trial is conducted by Beaujon Hospital and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 2 earlier versions

Jun 2017 — Apr 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Jun 2017 [monthly]

Recruiting NA

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beaujon Hospital

Data source: Beaujon Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Clichy, France